ACAS Logo Portfolio Company
BOSTON| CHICAGO| DALLAS| FRANKFURT| LONDON| LOS ANGELES| MADRID| NEW YORK| PALO ALTO| PARIS| WASHINGTON, DC

OUR PORTFOLIO

American Capital Portfolio Companies

NMCR, LLC

Visit the NMCR website
 
Call Principal and Managing Director Darin Winn at (214) 273-6630.
 
 
American Capital exited its investment in Network for Medical Communication and Research LLC in the first quarter of 2006
 

American Capital Recognizes $39 Million of Total Net Realized Gain From 9 Exits
Bethesda, MD - April 11, 2006 - American Capital Strategies Ltd. (Nasdaq:ACAS) announced today that it has received total proceeds of $268 million from exits and prepayments of nine portfolio companies, realizing a total net gain of $39 million. American Capital earned a positive 48%, 31%, 32%, 25%, 22%, 15%, 18%, 17% and a negative 49% compounded annual rate of return on its exited investments in these companies, including interest, dividends and fees earned over the life of American Capital's exited investments in the companies. [more...]

American Capital Invests $22 Million in Medical Education Company
Bethesda, MD - January 8, 2002 - American Capital Strategies Ltd. (Nasdaq:ACAS) announced today that it has invested $22 million to acquire an interest in Network for Medical Communication and Research LLC, a provider of specialized medical educational programs, research, and content for physicians and other medical personnel. American Capital's investment is in senior debt and senior and junior subordinated debt with warrants, and results in 50.1% ownership of the fully diluted equity. NMCR founders and management participated in the transaction in the form of an investment in the junior subordinated debt, the retention of a subordinated seller note, and the continued ownership of the balance of the fully diluted equity. [more...]

Medical Communications Network Added to American Capital Family
Since 1993 physicians interested in staying on top of the latest information about drugs and treatments for cancer have turned to the Network for Medical Communication & Research, LLC (NMCR). Through a variety of forums, NMCR gives doctors and other medical personnel an opportunity for educational exchange as new drugs are tested for FDA approval and come on the market for mainstream use. Founded by two prominent oncologists, NMCR has been an enormously successful venture, attracting top talent among academic physicians and earning the support of the ten largest manufacturers of oncology drugs. The company's meetings, events, and published materials maintain a broad-based, scientifically rigorous basis and are recognized and respected for their quality and integrity. [more...]

 
 
tombstone